Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-25 @ 4:15 AM
NCT ID:
NCT00122720
Eligibility Criteria:
Inclusion Criteria:
* Planned colonic and rectal surgery because of presumed cancer disease in the colon and rectum
Exclusion Criteria:
* Psychiatric disease or dementia
* Diseases, that renders participation in the study impossible
* Thromboembolic disease within the last three months
* Dysregulated hypertension (systolic blood pressure\>175 mmHg and/or diastolic blood pressure\>105 mmHg)
* Other diseases or causes that will contraindicate treatment with Darbepoetin Alfa
* Other diseases or causes that will contraindicate further treatment with Darbepoetin Alfa
* Patients that preoperatively and/or four days postoperatively have a hemoglobin concentration \> 14 g/dl
* Former cancer disease
* Disseminated cancer disease
* Rectal cancer stage T4
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00122720
Study Brief:
Protocol Section:
NCT00122720